Galectin Therapeutics Inc.
DE ˙ DB ˙ US3632252025
1,88 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:PHPN / Galectin Therapeutics Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership179,741 shares
Latest Disclosed Value $ 501,477
UBS Group AG reports 359.65% increase in ownership of PHPN / Galectin Therapeutics Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 179,741 shares of Galectin Therapeutics Inc. (DE:PHPN) valued at $402,620 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 39,104 shares of Galectin Therapeutics Inc.. This represents a change in shares of 359.65% during the quarter. The current value of the position is $337,913 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 179,741 140,637 359.65 501 209.26 0.0000
2026-01-29 2025-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 39,104 7,590 24.08 163 21.80 0.0000
2025-11-13 2025-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 31,514 -136,351 -81.23 133 -62.43 0.0000
2025-08-14 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 167,865 115,621 221.31 354 461.90 0.0001
2025-05-13 2025-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 52,244 464 0.90 64 -4.55 0.0000
2025-02-14 2024-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 51,780 37,448 261.29 67 69.23 0.0000
2024-11-14 2024-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 14,332 1,125 8.52 39 34.48 0.0000
2024-08-14 2024-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,207 13,207 30 0.0000
2024-05-13 2024-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -622 -100.00 0 -100.00
2024-02-09 2023-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 622 622 1 0.0000
2023-05-12 2023-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -5,561 -100.00 0 -100.00
2023-02-08 2022-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 5,561 5,561 6 0.0000
2022-11-10 2022-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -1,776 -100.00 0 -100.00
2022-08-10 2022-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 1,776 1,776 2 0.0000
2022-02-14 2021-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -1,988 -100.00 0 -100.00
2021-11-15 2021-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 1,988 988 98.80 8 166.67 0.0000
2021-08-13 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 1,000 -5,454 -84.51 3 -78.57 0.0000
2021-05-12 2021-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 6,454 -17,114 -72.62 14 -73.58 0.0000
2021-02-11 2020-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 23,568 20,572 686.65 53 562.50 0.0000
2020-11-12 2020-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 2,996 -9,405 -75.84 8 -78.95 0.0000
2020-07-31 2020-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 12,401 -12,608 -50.41 38 -22.45 0.0000
2020-05-01 2020-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 25,009 -26,310 -51.27 49 -66.67 0.0000
2020-02-14 2019-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 51,319 17,891 53.52 147 19.51 0.0001
2019-11-14 2019-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 33,428 15,348 84.89 123 64.00 0.0000
2019-08-14 2019-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 18,080 11,356 168.89 75 120.59 0.0000
2019-05-14 2019-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 6,724 -2,382 -26.16 34 9.68 0.0000
2019-02-14 2018-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 9,106 7,151 365.78 31 158.33 0.0000
2018-11-14 2018-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 1,955 -5,246 -72.85 12 -73.91 0.0000
2018-08-14 2018-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 7,201 1,079 17.62 46 58.62 0.0000
2018-05-15 2018-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 6,122 6,122 29 0.0000
2018-02-14 2017-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -6,643 -100.00 0 -100.00
2017-11-14 2017-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 6,643 4,230 175.30 14 133.33 0.0000
2017-11-14 2017-06-30 13F/A-1 GALECTIN THERAPEUTICS COM NEW 363225202 2,413 -1,292 -34.87 6 -33.33 0.0000
2017-08-14 2017-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 2,413 -1,292 6
2017-11-14 2017-03-31 13F/A-1 GALECTIN THERAPEUTICS COM NEW 363225202 3,705 2,864 340.55 9 800.00 0.0000
2017-05-12 2017-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 3,705 2,864 9
2017-02-14 2016-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 841 538 177.56 1 0.00 0.0000
2016-11-14 2016-09-30 13F GALECTIN THERAPEUTICS UNIT 03/28/2017 363225301 303 0 0.00 1 -88.89 0.0000
2016-08-12 2016-06-30 13F GALECTIN THERAPEUTICS UNIT 03/28/2017 363225301 303 0 0.00 0 0.0000
2016-08-12 2016-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 5,936 5,846 9 0.0000
2016-05-12 2016-03-31 13F GALECTIN THERAPEUTICS UNIT 03/28/2017 363225301 303 213 236.67 0 0.0000
2016-05-12 2016-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 90 -213 0
2016-02-16 2015-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 90 -213 -70.30 0 -100.00
2016-02-16 2015-12-31 13F GALECTIN THERAPEUTICS UNIT 03/28/2017 363225301 303 -2,654 1 0.0000
2015-11-13 2015-09-30 13F GALECTIN THERAPEUTICS UNIT 03/28/2017 363225301 303 50 19.76 2 100.00 0.0000
2015-11-13 2015-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 2,957 845 7 0.0000
2015-08-14 2015-06-30 13F GALECTIN THERAPEUTICS UNIT 03/28/2017 363225301 253 -1 -0.39 1 -50.00 0.0000
2015-08-14 2015-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 2,112 504 6 0.0000
2015-05-14 2015-03-31 13F GALECTIN THERAPEUTICS UNIT 03/28/2017 363225301 254 0 0.00 2 0.00 0.0000
2015-05-14 2015-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 1,608 -1,906 6 0.0000
2015-02-17 2014-12-31 13F GALECTIN THERAPEUTICS UNIT 99/99/9999 363225301 254 254 2 0.0000
2015-02-17 2014-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 3,514 3,260 12 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.